ROP CEO holds 87,311 direct, 92,808 indirect shares after sales

Rhea-AI Filing Summary

Roper Technologies (ROP) reported insider activity by its President and CEO/Director on 11/11/2025. The executive exercised 30,000 employee stock options at $186.75 and executed multiple open-market sales under a Rule 10b5-1 trading plan tied to an option award expiring November 17, 2025.

Weighted average sale prices were disclosed for several tranches, ranging from $441.973 to $448.3976. Following the transactions, beneficial ownership stands at 87,311 shares direct and 92,808 shares indirect (by limited partnership).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUNN LAURENCE NEIL

(Last) (First) (Middle)

C/O ROPER TECHNOLOGIES, INC.

6496 UNIVERSITY PARKWAY

(Street)

SARASOTA FL 34240

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ROPER TECHNOLOGIES INC [ ROP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/11/2025		M		30,000(1)	A	$186.75	117,311	D
Common Stock	11/11/2025		S		1,398(1)(2)	D	$441.973(2)	115,913	D
Common Stock	11/11/2025		S		14,143(1)(3)	D	$442.958(3)	101,770	D
Common Stock	11/11/2025		S		9,055(1)(4)	D	$443.6762(4)	92,715	D
Common Stock	11/11/2025		S		2,839(1)(5)	D	$444.7539(5)	89,876	D
Common Stock	11/11/2025		S		1,725(1)(6)	D	$445.5662(6)	88,151	D
Common Stock	11/11/2025		S		479(1)(7)	D	$446.6082(7)	87,672	D
Common Stock	11/11/2025		S		361(1)(8)	D	$448.3976(8)	87,311	D
Common Stock								92,808	I	by Limited Partnership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$186.75	11/11/2025		M			30,000(1)	(9)	11/17/2025	Common Shares	30,000	$186.75	0	D

Explanation of Responses:

1. Transaction effected pursuant to a Rule 10b5-1 trading plan with respect to an option award expiring on November 17, 2025.

2. This transaction was executed in multiple trades at prices ranging from $441.31 to $442.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $442.31 to $443.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. This transaction was executed in multiple trades at prices ranging from $443.31 to $444.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades at prices ranging from $444.32 to $445.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $445.33 to $446.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $446.33 to $447.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. This transaction was executed in multiple trades at prices ranging from $448.325 to $448.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

9. Options granted on November 17, 2015. Options vested 50% on November 17, 2017 and 50% on November 17, 2018.

	John K. Stipancich, attorney-in-fact	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ROP’s CEO report on Form 4?

The CEO exercised 30,000 stock options at $186.75 and sold shares in multiple trades under a Rule 10b5-1 plan on 11/11/2025.

What were the sale prices disclosed for ROP (ROP) shares?

Weighted average sale prices for tranches ranged from $441.973 to $448.3976, with notes providing the price ranges for each tranche.

How many ROP shares does the CEO own after these trades?

Post-transaction beneficial ownership is 87,311 shares direct and 92,808 shares indirect (by limited partnership).

Were the ROP transactions under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan for an option award expiring November 17, 2025.

What were the details of the option exercised by the ROP CEO?

An employee stock option with an $186.75 exercise price, granted on November 17, 2015, vested 50% on November 17, 2017 and 50% on November 17, 2018.

What roles does the reporting person hold at Roper Technologies (ROP)?

The reporting person is a Director and serves as President and CEO.